iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR)

Category Sector Equity Healthcare
star-filledstar-filled
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell

599.00p

Buy

600.75p

arrow-down-5.50p (-0.91%)

Prices updated at 17 May 2024, 16:00 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index.
FTSE All-Share
arrow-down-0.23%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Growth of 1,000 as of 18 May 2024, 06:05

Trailing returns (%) as of 18 May 2024, 06:05

Annual performance (%)

YearThis fundSector Equity Healthcare
31 Mar 13 - 31 Mar 14--
31 Mar 14 - 31 Mar 15--
31 Mar 15 - 31 Mar 16--
31 Mar 16 - 31 Mar 17--
31 Mar 17 - 31 Mar 1823.11-1.73
31 Mar 18 - 31 Mar 193.5415.33
31 Mar 19 - 31 Mar 20-4.351.86
31 Mar 20 - 31 Mar 2146.6522.68
31 Mar 21 - 31 Mar 22-9.883.51
31 Mar 22 - 31 Mar 23-6.77-0.56
31 Mar 23 - 31 Mar 243.574.92

Morningstar category: Sector Equity Healthcare

Trailing returns (%)

YearThis fundSector Equity Healthcare
1 Day-0.19-0.09
1 Month4.264.16
3 Months0.901.66
6 Months14.9510.93
1 Year-0.353.07
3 Years annualised-4.342.28
5 Years annualised4.576.60

Morningstar category: Sector Equity Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.